No. 98-3, 2020
Index
- A one-two punch: how qualified immunity's double dose of reasonableness dooms excessive force claims in the fourth circuit
- Emerging thoughts: a principled framework for regulating GenX as an emerging contaminant
- Insider trading as fraud
- Let's talk specifics: Why STI evidence should be treated as a 'specific instance' under rape shield laws
- Promoting therapeutic access by overcoming regulatory and legal barriers to a robust generic medical device market
- Recoupment patent